Genomic and Genetic Technologies in Clinical Practice Conference 2026

3billion is attending the Genomic and Genetic Technologies in Clinical Practice conference, taking place on June 3–4, 2026, at Narxoz Business School in Almaty, Kazakhstan.
The conference brings together clinical geneticists and genomic specialists to explore the expanding role of genetic technologies in routine clinical care. Our team is looking forward to contributing to that conversation with two presentations:
- Expanding Rare Disease Diagnosis: 3billion’s Evolving Genetic Solutions 12:30–13:00 | Minsoo Kim
- The Clinical Impact of Reanalysis in Rare Diseases 13:50–14:10 | Yoo Hyun Kim
The sessions will cover how genomic technologies are improving access to rare disease diagnosis, and how reanalysis of existing genetic data can surface new answers for patients who previously received inconclusive results. Together, they reflect 3billion’s focus on moving the diagnostic process forward—both for clinicians navigating complex cases and for patients still waiting for answers.
If you are attending the conference, we welcome the opportunity to connect. Stop by to meet our team, discuss your diagnostic challenges, and learn how 3billion’s genetic testing solutions can support your clinical work and research.
We look forward to seeing you in Almaty.
Get exclusive rare disease updates
from 3billion.

3billion Inc.
3billion is dedicated to creating a world where patients with rare diseases are not neglected in diagnosis and treatment.





